Clinical trials: Acute Infectious Conjunctivitis (Disorder)
Acute Infectious Conjunctivitis (Disorder)
The Efficacy Of SCH1 In The Treatment Of Acute Infectious Conjunctivitis
The objective of this study is to evaluate the efficacy of Sasch1, a novel anti-infective eyedrop, in the treatment of acute infectious conjunctivitis.
- Trial name
- SCH1TAIC (NCT05356793)
- Testing
- SCH-1
- Where
- United States
- Volunteers
- 30 people
- Sponsor
- Sacsh
Acute Infectious Keratoconjunctivitis
Study of INV-102 Ophthalmic Solution in Adults With Acute Infectious Keratoconjunctivitis
Phase 2, randomized study to assess topically administered eyedrops of INV-102 compared to vehicle during 1-week dosing in participants with Acute Infectious Keratoconjunctivitis (AIK).
- Trial name
- NCT05636228
- Testing
- INV-102, Vehicle
- Where
- 12 sites in United States, Thailand
- Volunteers
- 93 people
- Sponsor
- Invirsa, Inc.
SARS-CoV Infection, Pinkeye
RT-PCR on Conjunctival Sample for the Detection of SARS-CoV-2 in Patients With Covid-19
the purpose of the study is to study the detection of SARS-Cov-2 virus in the conjunctiva of covid-19 patients and the presence or absence of conjunctivitis in these patients
- Trial name
- P20/09 (NCT04397666)
- Testing
- conjunctival RT PCR
- Where
- France
- Volunteers
- 68 people
- Sponsor
- Versailles Hospital